Stock Analysis·← Pickers

HYPD

Hyperion DeFi, Inc.

Hyperion DeFi, Inc. (HYPD) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 46.0, with 0/3 trend checks passing.

Price
$3.02
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
46.0
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

HYPD with MA50 and MA200

14.9811.878.755.632.5207/3110/2401/2204/1707/15
HYPD2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$3.35-9.87% vs price
MA200
$4.29-29.53% vs price
RSI (14)
46.0Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
$2.80–$2.923.3% below price · 4 touches
Support Quality
4 touches0.9× zone volume
Chart Summary
Trend summary for HYPD

Hyperion DeFi, Inc. (HYPD) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $3.02, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 9.9% and below the 200-day moving average by 29.5%.

Momentum and stretch context

HYPD currently has an RSI reading of 46.0, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing HYPD next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Hyperion DeFi, Inc.

Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.

Sector
Healthcare
Industry
Medical - Devices
CEO
Hyunsu Jung
Employees
9
Market cap
$15.1M
Beta
2.50
52-week range
$2.49 – $15.89
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
2 Jul 2025
ISIN
US30234E2037
CUSIP
30234E203
Company profile data from Financial Modeling Prep. HYPD listed on NASDAQ.
Share dilution

HYPD shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Dec 2023Mar 2026
Shares outstanding (latest)
10.6M
Since Dec 2023
+1619.8%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. HYPD10 data points from Dec 2023 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about HYPD

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.